"Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.

Eid Rodríguez, Daniel

"Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia. [electronic resource] - PLoS neglected tropical diseases 11 2019 - e0007788 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1935-2735

10.1371/journal.pntd.0007788 doi


Antimony Sodium Gluconate--economics
Antiprotozoal Agents--economics
Bolivia
Budgets
Cost Savings
Cost-Benefit Analysis
Drug Costs
Health Care Costs
Humans
Leishmaniasis, Cutaneous--drug therapy
Meglumine Antimoniate--economics